Thermosensitive micelles-hydrogel hybrid system based on poloxamer 407 for localized delivery of paclitaxel

Journal of Pharmaceutical Sciences

Volumn 102, Issue 8, 2013, Pages 2707-2717

  Ju, Caoyun ^a   Sun, Juan ^a   Zi, Peng ^a   Jin, Xiang ^a   Zhang, Can ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Biomaterials; Cancer chemotherapy; Controlled release; Hydrogels; Localized delivery; Micelles; Poloxamer 407

Indexed keywords

CHITOSAN; GLUTARALDEHYDE; PACLITAXEL; POLOXAMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CROSS LINKING; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; DRUG TISSUE LEVEL; HEAT SENSITIVITY; HUMAN; HUMAN CELL; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MICELLE; MOUSE; NONHUMAN; TISSUE DISTRIBUTION; VISCOSITY;

EID: 84881022505     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23649     Document Type: Article

References (40)

1. Langer R, Vacanti JP. 1993. Tissue engineering. Science 5110:920-926.
2. Lu C, Yoganathan RB, Kociolek M, Allen C. 2013. Hydrogel containing silica shell cross-linked micelles for ocular drug delivery. J Pharm Sci 102:627-637.
3. Hurler J, Berg OA, Skar M, Conradi AH, Johnsen PJ, Skalko-Basnet N. 2012. Improved burns therapy: Liposomes-in-hydrogel delivery system for mupirocin. J Pharm Sci 101:3906-3915.
4. Shi W, Ji Y, Zhang X, Shu S, Wu Z. 2011. Characterization of ph- and thermosensitive hydrogel as a vehicle for controlled protein delivery. J Pharm Sci 100:886-895.
5. Nanjawade BK, Manvi FV, Manjappa AS. 2007. In situ-forming hydrogels for sustained ophthalmic drug delivery. J Control Release 122:119-134.
6. He C, Kim SW, Lee DS. 2008. In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery. J Control Release 127:189-207.
7. Huynh CT, Nguyen MK, Lee DS. 2011. Injectable block copolymer hydrogels: Achievements and future challenges for biomedical applications. Macromolecules 44:6629-6636.
8. Jose S, Ansa CR, Cinu TA, Chacko AJ, Aleykutty NA, Ferreira SV, Souto EB. 2012. Thermo-sensitive gels containing lorazepam microspheres for intranasal brain targeting. Int J Pharm 441:516-526.
9. Chen JP, Leu YL, Fang CL, Chen CH, Fang JY. 2011. Thermosensitive hydrogels composed of hyaluronic acid and gelatin as carriers for the intravesical administration of cisplatin. J Pharm Sci 100:655-666.
10. Chung TW, Lin SY, Liu DZ, Tyan YC, Yang JS. 2009. Sustained release of 5-FU from Poloxamer gels interpenetrated by crosslinking chitosan network. Int J Pharm 382:39-44.
11. Elstad NL, Fowers KD. 2009. OncoGel (ReGel/paclitaxel)-clinical applications for a novel paclitaxel delivery system. Adv Drug Deliv Rev 61:785-794.
12. Cao X, Geng J, Su S, Zhang L, Xu Q, Zhang L, Xie Y, Wu S, Sun Y, Gao Z. 2012. Doxorubicin-loaded Zein in situ gel for interstitial chemotherapy. Chem Pharm Bull (Tokyo) 60:1227-1233.
13. Cabana A, Ait-Kadi A, Juhasz J. 1997. Study of the gelation process of polyethylene oxidea-polypropylene oxideb-polyethylene oxidea copolymer (poloxamer 407) aqueous solutions. J Colloid Interface Sci 190:307-312.
14. Liu Y, Zhu YY, Wei G, Lu, WY. 2009. Effect of carrageenan on poloxamer-based in situ gel for vaginal use: Improved in vitro and in vivo sustained-release properties. Eur J Pharm Sci 37:306-312.
15. Guo DD, Xu CX, Quan JS, Song CK, Jin H, Kim DD, Choi YJ, Cho MH, Cho CS. 2009. Synergistic anti-tumor activity of paclitaxel-incorporated conjugated linoleic acid-coupled poloxamer thermosensitive hydrogel in vitro and in vivo. Biomaterials 30:4777-4785.
16. Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. 2006. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 23:2709-2728.
17. Jung HH, Park K, Han DK. 2010. Preparation of TGF-β1-conjugated biodegradable pluronic F127 hydrogel and its application with adipose-derived stem cells. J Control Release 147:84-91.
18. Amiji MM, Lai PK, Shenoy DB, Rao M. 2002. Intratumoral administration of paclitaxel in an in situ gelling poloxamer 407 formulation. Pharm Dev Technol 7:195-202.
19. Gou M, Li X, Dai M, Gong C, Wang X, Xie Y, Deng H, Chen L, Zhao X, Qian Z. 2008. A novel injectable local hydrophobic drug delivery system: Biodegradable nanoparticles in thermo-sensitive hydrogel. Int J Pharm 359:228-233.
20. Muzzarelli RAA, 1988. Carboxymethylated chitins and chitosans. Carbohydr Polym 8:1-21.
21. Muzzarelli RAA. 2009. Chitins and chitosans for the repair of wounded skin, nerve, cartilage and bone. Carbohydr Polym 76:167-182.
22. Li X, Chen S, Zhang B, Li M, Diao K, Zhang Z, Li J, Xu Y, Wang X, Chen H. 2012. In situ injectable nano-composite hydrogel composed of curcumin, N, O-carboxymethyl chitosan and oxidized alginate for wound healing application. Int J Pharm 437:110-119.
23. Panchagnula R. 1998. Pharmaceutical aspects of paclitaxel. Int J Pharm 172:1-15.
24. Hawkins MJ, Soon-Shiong P, Desai N. 2008. Protein nanoparticles as drug carriers in clinical medicine. Adv Drug Deliv Rev 60:876-885.
25. Mo R, Jin X, Li N, Ju C, Sun M, Zhang C, Ping Q. 2011. The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles. Biomaterials 32:4609-4620.
26. Zhang C, Qu G, Sun Y, Wu X, Yao Z, Guo Q, Ding Q, Yuan S, Shen Z, Ping Q, Zhou H. 2008. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Biomaterials 29:1233-1241.
27. Gratieri T, Gelfuso GM, Rocha EM, Sarmento VH, de Freitas O, Lopez RFV. 2010. A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery. Eur J Pharm Biopharm 75:186-193.
28. Dang QF, Yan JQ, Li JJ, Cheng XJ, Liu CS, Chen XG. 2011. Controlled gelation temperature, pore diameter and degradation of a highly porous chitosan-based hydrogel. Carbohydr Polym 83:171-178.
29. Ta HT, Dass CR, Larson I, Choong PF, Dunstan DE. 2009. A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma. Biomaterials 30:3605-3613.
30. Wei L, Cai C, Lin J, Chen T. 2009. Dual-drug delivery system based on hydrogel/micelle composites. Biomaterials 30:2606-2613.
31. Jones DS, Woolfson AD, Brown AF. 1997. Textural, viscoelastic and mucoadhesive properties of pharmaceutical gels composed of cellulose polymers. Int J Pharm 151:223-233.
32. Chen MC, Tsai HW, Liu CT, Peng SF, Lai WY, Chen SJ, Chang Y, Sung HW. 2009. A nanoscale drug-entrapment strategy for hydrogel-based systems for the delivery of poorly soluble drugs. Biomaterials 30:2102-2111.
33. Zhang L, Parsons DL, Navarre C, Kompella UB, 2002. Development and in-vitro evaluation of sustained release Poloxamer 407 (P407) gel formulations of ceftiofur. J Control Release 85:73-81.
34. Al-Abd AM, Hong KY, Song SC, Kuh HJ. 2010. Pharmacokinetics of doxorubicin after intratumoral injection using a thermosensitive hydrogel in tumor-bearing mice. J Control Release 142:101-107.
35. Yang Y, Wang J, Zhang X, Lu W, Zhang Q. 2009. A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel. J Control Release 135:175-182.
36. Lin HR, Sung KC. 2000. Carbopol/pluronic phase change solutions for ophthalmic drug delivery. J Control Release 29:379-388.
37. Peppas NA, Bures P, Leobandung W, Ichikawa H. 2000. Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm 50:27-46.
38. El-Sherbiny IM, Lins RJ, Abdel-Bary EM, Harding DRK. 2005. Preparation, characterization, swelling and in vitro drug release behaviour of poly [N-acryloylglycine-chitosan] interpolymeric pH and thermally-responsive hydrogels. Eur Polym J 41:2584-2591.
39. Lopes NM, Adams EG, Pitts TW, Bhuyan BK. 1993. Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines. Cancer Chemother Pharmacol 32:235-242.
40. Batrakova EV, Kabanov AV. 2008. Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release 130:98-106.